NIOX Group Future Growth
Future criteria checks 1/6
NIOX Group's earnings is forecasted to decline at -2.9% per annum while its annual revenue is expected to grow at 13.9% per year. EPS is expected to decline by 5.1%. Return on equity is forecast to be 11.4% in 3 years.
Earnings growth rate
EPS growth rate
|Biotechs earnings growth||49.4%|
|Revenue growth rate||13.9%|
|Future return on equity||11.4%|
|Last updated||24 May 2023|
Recent future growth updates
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 82C's earnings are forecast to decline over the next 3 years (-2.9% per year).
Earnings vs Market: 82C's earnings are forecast to decline over the next 3 years (-2.9% per year).
High Growth Earnings: 82C's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 82C's revenue (13.9% per year) is forecast to grow faster than the German market (4.3% per year).
High Growth Revenue: 82C's revenue (13.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 82C's Return on Equity is forecast to be low in 3 years time (11.4%).